DWP
NUVB icon

Daymark Wealth Partners’s Nuvation Bio NUVB Stock Holding History

Daymark Wealth Partners’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$322K Buy
+56,734
New +$277K 0.01% 609

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Daymark Wealth Partners's NUVB Position: Q2 2026 in Review

Daymark Wealth Partners opened a new position in Nuvation Bio (NUVB) in Q2 2026: 56,734 shares worth $322K. The stake represents 0.01% of the portfolio and ranks #609 among its holdings.

244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Daymark Wealth Partners held 56,734 shares of Nuvation Bio worth $322K as of Q2 2026.
  • Nuvation Bio was a new Daymark Wealth Partners position in Q2 2026.
  • Nuvation Bio made up 0.01% of Daymark Wealth Partners's portfolio in Q2 2026, its #609 holding.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Daymark Wealth Partners's 13F filing for Q2 2026, filed 31 Jul 2026.